XBI is trading at +3.01% now at $151.46 after extending a multi-day biotech rally.
- The move is driven by broader biotechnology sector momentum and a strengthening of investor risk appetite.
- Gains come amid a supportive backdrop for U.S. equities and a rotation into higher-beta healthcare exposure.